Mikio Kakumoto

MDR1 Genotype-Related Pharmacokinetics of Digoxin After Single Oral Administration in Healthy Japanese Subjects

Toshiyuki Sakaeda, Tsutomu Nakamura, Masanori Horinouchi et al. · Pharmaceutical Research · 2001 · 320 citations

Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes.

Takuji Tanaka, Kohei Kawabata, Mikio Kakumoto et al. · PubMed · 1998 · 130 citations

Nutrition, Auraptene Administration, Citrus Auraptene +15

Intravenous Infusion of an Antisense Oligonucleotide Results in Exon Skipping in Muscle Dystrophin mRNA of Duchenne Muscular Dystrophy

Yasuhiro Takeshima, Mariko Yagi, Hiroko Wada et al. · Pediatric Research · 2006 · 100 citations · Full text

Exon Skipping, Antisense Oligonucleotide Results, Skeletal Muscle +9

Effect of micafungin on cytochrome P450 3A4 and multidrug resistance protein 1 activities, and its comparison with azole antifungal drugs

Toshiyuki Sakaeda, Koichi Iwaki, Mikio Kakumoto et al. · Journal of Pharmacy and Pharmacology · 2005 · 98 citations · Full text

Cytochrome P450 3A4, Drug Resistance Analysis, Antifungal Agent +15

Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis

Kunihiro Kawabata, Takuji Tanaka, Shiro Honjo et al. · International Journal of Cancer · 1999 · 93 citations